Pigmented progressive purpuric dermatosishttps://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
Pigmented progressive purpuric dermatosis ໝາຍເຖິງສະພາບຜິວໜັງທີ່ບໍ່ມີອາການຄັນ, ມີລັກສະນະການເກີດຂອງຜິວໜັງ purpuric. ຂະໜາດຂອງບາດແຜ່ມີຊ່ວງຈາກ 0.3 ຫາ 1 ຊຕມ ແລະສ່ວນໃຫຍ່ມັກຈະເຫັນໃນປາຍຕ່ໍາ. ການໃຊ້ cortisone ຈະຊ່ວຍບັນທຶກອາການຄັນ ແລະປັບປຸງການປ່ຽນສີຂອງຜິວໜັງ. Pigmented progressive purpuric dermatosis ບໍ່ມີອາການອື່ນນອກຈາກການປ່ຽນສີຂອງຜິວໜັງ. ບາດແຜ່ມັກເກີດຂຶ້ນໃນປີກລຸ່ມສຸດ, ແຕ່ອາດເກີດໄດ້ທົ່ວຮ່າງກາຍ, ລວມທັງມື, ແຂນ, ລຳຕົວ ແລະແມ່ກະທັ້ງຄໍ.

ການປິ່ນປົວ ― OTC Drugs
ຢາຂີ້ເຜິ້ງ OTC steroid
#Hydrocortisone ointment
#Hydrocortisone cream
☆ AI Dermatology — Free Service
ໃນປີ 2022 Stiftung Warentest ຜົນໄດ້ຮັບຈາກເຢຍລະມັນ, ຄວາມພໍໃຈຂອງຜູ້ບໍລິໂພກກັບ ModelDerm ແມ່ນຕໍ່າກວ່າການປຶກສາຫາລືທາງດ້ານການປິ່ນປົວທາງໂທລະສັບເລັກນ້ອຍເທົ່ານັ້ນ.
  • Schamberg disease - ເພດຊາຍ, ອາຍຸ 26 ປີ, ມີອາການຜິວໜັງອັກເສບ ແລະ ມີອາການ telangiectasia ທີ່ຂາຍ.
    References Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 
    NIH
    Pigmented purpuric dermatoses (PPD) ແມ່ນກຸ່ມຂອງສະພາບຜິວໜັງທີ່ມີຈຸດນ້ອຍໆຂອງເສັ້ນເລືອດໃຕ້ຜິວໜັງ, ເນື່ອງຈາກການອັກເສບຂອງເສັ້ນປະສາດ. PPD ປົກກະຕິແລ້ວເລີ່ມເປັນຈຸດສີແດງ, ຫາສີມ່ວງ, ແລະຕໍ່ມາປ່ຽນເປັນສີທອງ‑ສີນ້ຳຕານ ເພາະ hemosiderin ຖືກດູດຊຶມຄືນ.
    Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
     Schamberg Disease 32809367 
    NIH
    Schamberg disease ເປັນປະເພດທີ່ພົບເລື້ອຍທີ່ສຸດຂອງ pigmented purpuric dermatoses (PPDs) ເຊິ່ງແມ່ນສະພາບຜິວໜັງຊຳເຮື້ອ ມີຈຸດສີແດງ ຫຼື ສີມ່ວງ ແລະສີຜິວໜັງເພີ່ມຂຶ້ນ (ເປັນຈຸດສີນ້ຳຕານ, ສີແດງ ຫຼື ສີເຫຼືອງ)​. PPDs ຈັດ່ແບບເປັນຫ້າປະເພດ: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot‑Blum purpura, eczematoid‑like purpura of Doucas and Kapetanakis. Schamberg disease (SD) ຍັງເອີ້ນວ່າ progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressiva, Schamberg's purpura. ສ່ວນຫຼາຍມັກຈະເກີດໃນຜູ້ຊາຍ ແລະມັກເລີ່ມຕົ້ນຢູ່ຂາຕ່ໍາ, ແຕ່ສາມາດເກີດໄດ້ທັ່ງຢູ່ຕົ້ນຂາ, ກົ້ນ, ລໍາຕົ້ນ ຫຼື ແຂນ.
    Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
     Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 
    NIH
    ຂໍ້ມູນກ່ຽວກັບຄົນເຈັບ 113 ຄົນທີ່ມີ PPD ໄດ້ຖືກວິເຄາະ, ລວມທັງ 38 ຄົນທີ່ໄດ້ຮັບການກວດຜິວໜັງສໍາລັບການສຶກສານີ້. ປະເພດທາງຄລີນິກທີ່ສຸດແມ່ນ ພະຍາດ Schamberg (60.5%). ເງື່ອນໄຂອື່ນໆ ທີ່ຄຽງຄູ່ກັບ PPD ແມ່ນ hypertension (15.8%), ພະຍາດເບົາຫວານ (10.5%) ແລະອື່ນໆ. ປະຫວັດການໃຊ້ຢາເປັນສ່ວນປະກອບຂອງ statins (13.2%), beta blockers (10.5%) ແລະອື່ນໆ. ປັດໃຈທີ່ກ່ຽວຂ້ອງກັບ PPD ລວມມີ ການຕິດເຊື້ອທາງເດີນຫາຍໃຈທາງເທິງ (5.3%), ການຢືນເປັນເວລາດົນເຮັດໃຫ້ການກົດແດນ orthostatic ສູງ (2.6%) ແລະ ການອອກກໍາລັງກາຍແບບຫນັກແຫນ້ນ (2.6%). ການປິ່ນປົວໄດ້ຖືກປະຕິບັດໃຫ້ຄົນເຈັບ 36 ຄົນ (94.7%) ດ້ວຍ oral antihistamines, pentoxifylline, topical steroids ແລະ/ຫຼື phototherapy.
    Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.